Speaking at a webinar back in September 2021, Prof. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins School of Medicine, presented his research on psilocybin and its potential for positive long term outcomes in both healthy participants and in individuals with psychiatric disorders.
Speaking at a webinar in July 2021, David Vaillencourt, CEO of The GMP Collective and Darwin Millard, The Spock of Cannabis, presented an update on cannabis testing standards for 2021.
Speaking at a webinar back in April 2021, Morgan Boyle, Lead Microbiologist and Cannabis Science Consultant, presented her talk on the current status of microbial testing requirements.
Speaking at a webinar in July 2021, Gül Dölen, Associate Professor of Neuroscience at The Johns Hopkins University, presented her research into the therapeutic effects and the mechanism of action of MDMA.
Speaking at an Analytical Cannabis webinar in January 2022, Kim Ross, PhD, Chief Science Officer at Peak Compliance LLC, presented her talk on hemp regulation, testing and standardization.
Speaking at a webinar in March 2021, Alisia Ratliff, CEO of Victus Capital Ventures, presented the history of extraction and methodologies as well as what the future holds.
This video, courtesy of the Neuroscientifically Challenged YouTube channel, discusses the effects of THC on the nervous system.
Speaking at a webinar in February 2021, Chris Tasker, Chief Executive Officer of Global Cannabinoid Solutions presented about current UK cannabis legislation and proposed law improvements within the UK.
Speaking at a webinar in March 2021, Cosmo Feilding-Mellen, Co-Founder & Chief Executive of Beckley Psytech, explored the promising medical qualities of psychedelics, such as LSD and psilocybin “magic” mushrooms
Speaking at a webinar in February 2021, Dr Natalia Sannikova, Research & Development Manager and Tomas Skrinskas, Founder & CEO from Ascension Sciences presented their research of cannabinoid nanoparticles.